Market Place
Sourcing Support
FDA approves Autolus’ CAR-T cell therapy for aggressive blood cancer
12 Nov 2024 //
ENDPTS
BioNTech pays Autolus $250M to use manufacturing, CAR-T tech
08 Feb 2024 //
FIERCE BIOTECH
Autolus eyes November for potential US approval of Tecartus rival
22 Jan 2024 //
ENDPTS
Biotech CAR-T roundup: Autolus, Gracell tout early-stage data at #ASH23
12 Dec 2023 //
ENDPTS
Autolus tips its hand, bags $220M as CAR-T showdown with Gilead looms
09 Dec 2022 //
ENDPTS
Autolus outlines path to FDA after CAR-T trial hits endpoint
09 Dec 2022 //
FIERCEBIOTECH
Autolus Therapeutics to Present Three Clinical Data Updates at the (ASH)
03 Nov 2022 //
BARRONS
Moderna licenses Autolus` targeting tech for cancer project
13 Oct 2022 //
FIERCEBIOTECH
BMS inks 2nd biotech deal in one day, this time with Autolus
05 Oct 2022 //
FIERCEBIOTECH
Autolus Therapeutics Announces Collaboration with BMS for Use of Autolu
04 Oct 2022 //
GLOBENEWSWIRE
Autolus Therapeutics to Present Four Clinical Data Updates at the EHA
12 May 2022 //
GLOBENEWSWIRE
Autolus Therapeutics Reports First Quarter 2022 Financial Results
05 May 2022 //
GLOBENEWSWIRE
Autolus Therapeutics to Present Three Novel Cell Programming Approaches at ASGCT
02 May 2022 //
GLOBENEWSWIRE
Autolus Therapeutics to Report First Quarter 2022 Financial Results
25 Apr 2022 //
GLOBENEWSWIRE
FDA Grants Regenerative Medicine Advanced Therapy (RMAT) designation
25 Apr 2022 //
GLOBENEWSWIRE
Autolus Receives EMA OMP Designation for obe-cel in Acute Lymphoblastic Leukemia
31 Mar 2022 //
GLOBENEWSWIRE
Autolus Therapeutics to Participate in Conferences During April 2022
29 Mar 2022 //
GLOBENEWSWIRE
Autolus Tx Reports Q4 and FY 2021 Financial Results and Operational Progress
10 Mar 2022 //
GLOBENEWSWIRE
Autolus Tx Announces Publication Describing Novel Cell Programming Technology
03 Mar 2022 //
GLOBENEWSWIRE
Autolus Tx to Report Q4 and Full Year 2021 Financial Results on March 10
21 Feb 2022 //
GLOBENEWSWIRE
Autolus announces retirement of chief financial officer and succession plan
10 Jan 2022 //
GLOBENEWSWIRE
Autolus announces publication describing its small molecule CAR T cells
10 Nov 2021 //
GLOBENEWSWIRE
Blackstone bets on Autolus` CD19 CAR-T in $250M deal
09 Nov 2021 //
WALLSTREETJOURNAL
Autolus Therapeutics to Present New Data at the 63rd ASH
04 Nov 2021 //
GLOBENEWSWIRE
Autolus provides an update on its manufacturing facility in Stevenage
16 Sep 2021 //
GLOBENEWSWIRE
Autolus announces the appointment of John H. Johnson as non-executive chairman
15 Sep 2021 //
GLOBENEWSWIRE
Autolus Therapeutics publishes obe-cel (AUTO1) PI ALLCAR19 data in r/r B-ALL
01 Sep 2021 //
GLOBENEWSWIRE
Moderna looks to Autolus to fuel its mRNA oncology plans
03 Aug 2021 //
FIERCEBIOTECH
Autolus and Moderna sign Option and License Agreement
02 Aug 2021 //
GLOBENEWSWIRE
Autolus Announces Appointment of Edgar Braendle as Chief Development Officer
15 Jul 2021 //
GLOBE NEWSWIRE
Autolus Therapeutics to Report Second Quarter 2021 Financial Results
08 Jul 2021 //
GLOBENEWSWIRE
Autolus Therapeutics Announces ILAP designation for obe-cel
15 Jun 2021 //
GLOBENEWSWIRE
Autolus Therapeutics Announces an Additional Nature Publication for AUTO1
25 May 2021 //
GLOBENEWSWIRE
Autolus to Present New Data on AUTO1 at the EHA Virtual Congress
12 May 2021 //
GLOBENEWSWIRE
Autolus Therapeutics Receives Innovation Passport and entry into ILAP for AUTO4
20 Apr 2021 //
GLOBENEWSWIRE
Autolus Therapeutics Receives PRIME designation for AUTO1 for the treatment
01 Apr 2021 //
GLOBENEWSWIRE
TCR² plants its flag in former Autolus site, planning to add 175 jobs
31 Mar 2021 //
ENDPTS
Autolus Therapeutics Announces Updated Manufacturing Facility Strategy
29 Mar 2021 //
GLOBENEWSWIRE
Autolus Announces Closing of Public Offering and Full Exercise of Option
12 Feb 2021 //
BIOSPACE
Autolus to ax staff, offload asset as lead CAR-T nears key data
06 Jan 2021 //
FIERCEBIOTECH
Autolus presents additional data on AUTO3 in DLBCL during the 62nd ASH
07 Dec 2020 //
GLOBENEWSWIRE
Autolus announces publication of new AUTO6 Phase 1 data in childhood
30 Nov 2020 //
GLOBENEWSWIRE
Autolus provides glimpse of next-generation CAR-T program
18 Sep 2020 //
ENDPTS
Autolus Therapeutics presents additional data on AUTO3 in DLBCL
18 Sep 2020 //
GLOBENEWSWIRE
Positive Pivotal Data for Libtayo® (cemiplimab) Monotherapy Featured
17 Sep 2020 //
BIOSPACE
Autolus Therapeutics presents data on AUTO3 in DLBCL
17 Sep 2020 //
BIOSPACE
Autolus Therapeutics presents additional data on AUTO3 in DLBCL
29 May 2020 //
GLOBENEWSWIRE
Autolus Therapeutics to Present New Data on AUTO1 & AUTO3 at the 2020 EHA
15 May 2020 //
GLOBENEWSWIRE
Autolus Therapeutics to Present New Data on AUTO3 during the ASCO20
13 May 2020 //
GLOBENEWSWIRE
Autolus Presents Encouraging Additional Data Showcasing Clinical Progress
30 Jan 2020 //
GLOBENEWSWIRE
